Innovation and Scientific Collaboration Moved the Generic Drug Program Forward In 2021

[FDA]

2021 was a productive year for the agency’s generic drug program. Even with the unique challenges caused by the ongoing pandemic, OGD continued to innovate and conduct scientific research to keep the program moving forward.


Baca selengkapnya di : http://www.fda.gov...